Phytochemical profiling, pharmacology prediction, and molecular docking study of Chromolaena odorata extract against multiple target proteins in wound healing
Open Access
- 10 August 2023
- journal article
- research article
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 12 (4) , 469-482
Abstract
Introduction: Wounds have a significant influence on socioeconomic and the quality of life. Many attempts have been taken to produce advanced wound dressing to fulfill demands. The incorporation of natural therapeutics like medicinal plants in wound dressings is currently popular. However, several medications have failed to enter the market due to inadequate pharmacokinetics data. Computer-aided tools are now available as advanced drug discovery methods, which can be used to screen pharmaceuticals from phytochemicals found in various medicinal plants. This study aims to evaluate the phytoconstituents of Chromolaena odorata extract and its pharmacological potential as a wound-healing agent. Methods: Phytoconstituents from C. odorata were identified using qualitative screening methods and gas chromatography-mass spectrometry (GC-MS), and their mechanistic properties were assessed using molecular docking and SwissADME tools. Results: Current works revealed that the topmost phytoconstituents in C. odorata were phytol (49.83%), hexadecanoic acid ethyl ester (9.40%), linolenic acid (8.07%), and squalene (3.53%). Through SwissADME analysis, all four topmost compounds obeyed Lipinski’s Rule of 5. In silico molecular docking study of these top phytoconstituents against several protein targets involved in wound healing revealed that squalene had the highest binding affinity to GSK3-β (-6.8 kJ/ mol), MMP-9 (-7.4 kJ/mol), and COX-2 (-8.6 kJ/mol) as compared to other ligands (phytol, linolenic acid, and hexadecenoic acid ethyl ester). Conclusion: These findings suggest that the most prominent compound that contributes to C. odorata’s wound healing capacity is squalene and the incorporation of C. odorata in potential wound dressing formulation is justified.Keywords
This publication has 39 references indexed in Scilit:
- Molecular docking study of xylogranatins binding to glycogen synthase kinase-3βDigital Chinese Medicine, 2022
- COX‐2 inhibition does not alter wound healing outcomes of a volumetric muscle loss injury treated with a biologic scaffoldJournal of Tissue Engineering and Regenerative Medicine, 2020
- Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19International Journal of Antimicrobial Agents, 2020
- Selective inhibition of COX-2 improves cutaneous wound healing of pressure ulcers in mice through reduction of iNOS expressionLife Sciences, 2016
- In Silico Drug-Designing Studies on Flavanoids as Anticolon Cancer Agents: Pharmacophore Mapping, Molecular Docking, and Monte Carlo Method-Based QSAR ModelingInterdisciplinary Sciences: Computational Life Sciences, 2016
- Molecular docking and dynamic studies of bioactive compounds from Naravelia zeylanica (L.) DC against glycogen synthase kinase-3β proteinJournal of Taibah University for Science, 2015
- The Rule of Five for Non-Oral Routes of Drug Delivery: Ophthalmic, Inhalation and TransdermalPharmaceutical Research, 2010
- Matrix metalloproteinase-9 delays wound healing in a murine wound modelSurgery, 2010
- Wound healing activity and docking of glycogen-synthase-kinase-3-β-protein with isolated triterpenoid lupeol in ratsPhytomedicine, 2008
- Antimicrobial effects of Thai medicinal plants against acne-inducing bacteriaJournal of Ethnopharmacology, 2005